Literature DB >> 8194898

Third International Workshop on Lung Tumor and Differentiation Antigens: overview of the results of the central data analysis.

R A Stahel1, W R Gilks, H P Lehmann, T Schenker.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8194898     DOI： 10.1002/ijc.2910570704

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN： 0898-6924


× No keyword cloud information.
  23 in total

1.  Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation.

Authors:  T Ashida; M Higashishiba; Y Sumimoto; T Sano; H Miyazato; T Shimada; J Miyatake; K Kawanishi; Y Tatsumi; A Kanamaru
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.

Authors:  W A Franklin; E J Shpall; P Archer; C S Johnston; S Garza-Williams; L Hami; M A Bitter; R C Bast; R B Jones
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

4.  Usefulness of quantifying serum KL-6 levels in the follow-up of uveitic patients with sarcoidosis.

Authors:  Nobuyoshi Kitaichi; Toshihide Ariga; Satoru Kase; Kauzhiko Yoshida; Kenichi Namba; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

5.  Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.

Authors:  Amal Gad; Eiji Tanaka; Akihiro Matsumoto; Moushira Abd-el Wahab; Abd el-Hamid Serwah; Fawzy Attia; Khalil Ali; Howayda Hassouba; Abd el-Raoof el-Deeb; Tetsuya Ichijyo; Takeji Umemura; Hidetomo Muto; Kaname Yoshizawa; Kendo Kiyosawa
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

6.  Detection and characterization of carcinoma cells in the blood.

Authors:  E Racila; D Euhus; A J Weiss; C Rao; J McConnell; L W Terstappen; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody.

Authors:  Kenji Matsumura; Ichiro Niki; Hui Tian; Masahisa Takuma; Norio Hongo; Shunro Matsumoto; Hiromu Mori
Journal:  Radiat Med       Date:  2008-04

8.  Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.

Authors:  Masaki Tomita; Takanori Ayabe; Eiichi Chosa; Naohiro Nose; Kunihide Nakamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-08-11

9.  Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis.

Authors:  Francesco Bonella; Shinichiro Ohshimo; Cai Miaotian; Matthias Griese; Josune Guzman; Ulrich Costabel
Journal:  Orphanet J Rare Dis       Date:  2013-04-04       Impact factor: 4.123

10.  KL-6, a Human MUC1 Mucin, as a prognostic marker for diffuse alveolar hemorrhage syndrome.

Authors:  Yoshiko Kida; Shinichiro Ohshimo; Kohei Ota; Tomoko Tamura; Tadatsugu Otani; Kazunobu Une; Takuma Sadamori; Yasumasa Iwasaki; Francesco Bonella; Noboru Hattori; Nobuyuki Hirohashi; Josune Guzman; Ulrich Costabel; Nobuoki Kohno; Koichi Tanigawa
Journal:  Orphanet J Rare Dis       Date:  2012-12-17       Impact factor: 4.123
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.